J. Maidens
Guy's and St Thomas' NHS Foundation Trust(GB)Royal North Shore Hospital(AU)Royal Hobart Hospital(AU)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, DNA Repair Mechanisms, Immune Cell Function and Interaction, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma(2018)282 cited
- → Prognostic gene expression signature for high-grade serous ovarian cancer(2020)170 cited
- → Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses(2020)38 cited
- → MyD88 and TLR4 Expression in Epithelial Ovarian Cancer(2018)30 cited
- → BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance(2024)24 cited
- → Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer(2024)14 cited
- → Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer(2023)5 cited
- → 395 The Educational Needs of Nurses Caring for Women With Gynaecological Cancer in New South Wales, Australia(2004)1 cited